STAAR Surgical Co
NASDAQ:STAA

Watchlist Manager
STAAR Surgical Co Logo
STAAR Surgical Co
NASDAQ:STAA
Watchlist
Price: 23.12 USD -3.18% Market Closed
Market Cap: 1.1B USD
Have any thoughts about
STAAR Surgical Co?
Write Note

Operating Margin
STAAR Surgical Co

7.5%
Current
12%
Average
4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
7.5%
=
Operating Profit
25.7m
/
Revenue
341.2m

Operating Margin Across Competitors

Country US
Market Cap 1.1B USD
Operating Margin
8%
Country JP
Market Cap 7.1T JPY
Operating Margin
28%
Country CH
Market Cap 37.7B CHF
Operating Margin
13%
Country DK
Market Cap 177.1B DKK
Operating Margin
27%
Country US
Market Cap 16.1B USD
Operating Margin
17%
Country KR
Market Cap 10.5T KRW
Operating Margin
-245%
Country CN
Market Cap 51.1B CNY
Operating Margin
45%
Country US
Market Cap 6.5B USD
Operating Margin
32%
Country CA
Market Cap 6.4B USD
Operating Margin
4%
Country UK
Market Cap 4.6B GBP
Operating Margin
13%
Country US
Market Cap 5.6B USD
Operating Margin
12%
No Stocks Found

STAAR Surgical Co
Glance View

Market Cap
1.1B USD
Industry
Health Care

In the early throes of medical innovation, STAAR Surgical Co. carved a niche within the ophthalmic industry, where its focus on implantable lenses set it apart from many contemporaries. Based in Monrovia, California, the company began its journey by enhancing an integral component of human life: vision. Through the skillful development and manufacture of implantable collamer lenses (ICLs), STAAR Surgical has thrived by providing solutions for those seeking alternatives to laser-based surgeries. Its ICL technology directly targets issues like myopia (nearsightedness) and astigmatism, offering patients a reversible, less invasive option than traditional corrective procedures. STAAR Surgical's business model hinges on a blend of specialized technology and strategic market penetration. The company primarily generates revenue by selling its suite of implantable lenses to healthcare providers and clinics worldwide, capitalizing on the rising trend of elective vision correction procedures. With its innovation-driven credo, STAAR continually invests in R&D to enhance its product offerings, ensuring it remains at the forefront of eye-care technology. By targeting emerging markets and expanding its global footprint, particularly in regions with growing demand for premium vision solutions, STAAR has positioned its unique value proposition to capitalize on both technological advancements and changing patient preferences. Through this deliberate strategy, STAAR not only bolsters its revenue streams but also fortifies its presence as a key player in the ophthalmic landscape.

STAA Intrinsic Value
26.42 USD
Undervaluation 13%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
7.5%
=
Operating Profit
25.7m
/
Revenue
341.2m
What is the Operating Margin of STAAR Surgical Co?

Based on STAAR Surgical Co's most recent financial statements, the company has Operating Margin of 7.5%.